“111, Inc. Reinstated on NASDAQ: A Heartfelt Journey of Regaining Compliance”

Exciting News for 111, Inc.

Reshaping the Healthcare Industry

February 11, 2025

It is with great pleasure that we announce that 111, Inc. (NASDAQ: YI) has recently received notification from The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Listing Rule 5450(a)(1). This achievement is a testament to our commitment to reshaping the value chain of the healthcare industry in China by digitally empowering both the upstream and downstream sectors.

Over the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company’s American Depositary Shares has been at $1.00 per share or greater. This milestone underscores our dedication to driving innovation and creating value for our shareholders.

At 111, Inc., we believe in leveraging technology to revolutionize the way healthcare is delivered in China. By providing a tech-enabled platform that connects all stakeholders in the healthcare ecosystem, we aim to improve access to quality care, enhance efficiency, and ultimately improve health outcomes for individuals across the country.

This achievement would not have been possible without the hard work and dedication of our team, as well as the trust and support of our investors and partners. We are excited about the future of 111, Inc. and look forward to continuing our mission of transforming the healthcare industry in China.

How This Will Affect You:

As a shareholder of 111, Inc., you can expect to see positive results following this announcement. With the Company regaining compliance with Nasdaq Listing Rule 5450(a)(1), there is potential for increased investor confidence and improved stock performance. This could have a direct impact on the value of your investment in 111, Inc., leading to potential returns and growth in the future.

How This Will Affect the World:

The regaining of compliance by 111, Inc. with Nasdaq Listing Rule 5450(a)(1) reflects positively on the healthcare industry as a whole. By demonstrating a commitment to innovation and value creation, 111, Inc. sets a precedent for other companies in the sector to prioritize technology and digital empowerment. This can potentially drive positive change and advancements in healthcare delivery on a global scale.

Conclusion:

As we celebrate this significant milestone for 111, Inc., we are grateful for the opportunities that lie ahead. Our journey to reshape the healthcare industry in China continues, and we are committed to driving positive impact and transformation through technology and innovation. Thank you to all our stakeholders for your continued support and trust in our vision. Together, we will create a healthier and more connected future for all.

Leave a Reply